We’re proud to announce that SanaClis has once again earned the prestigious AAA credit rating...
Team SanaClis attended Fierce JPM Week in January, joining pharma, biopharma and healthcare leaders to shape 2025! With fresh regulations, shifting trends, and evolving industry dynamics, the spotlight was on innovative strategies.
Our VP, John Murray, deep-dived into "Innovative Risk-Sharing Models for Biotech Success", explore cutting-edge strategies that can reshape the future of our industry, providing invaluable insights into:- Performance-Based Models: Share financial risks with clear goals and incentives for strategic alignment.
- Revenue Sharing for Biotech: Support smaller firms and innovative therapies with shared financial burdens and future revenue potential.
- Hybrid Approaches: Combine milestone-based payments with revenue-sharing elements to balance commitment and flexibility.
In case you missed the presentation, feel free to reach out.
This past weekend teams from across our European offices, joined by our founding partners,...
SanaClis is proud to once again stand behind the Žampa Cup Ski Race - an uplifting tradition...